Biotarget最新文献_第3页

Long noncoding RNA MALAT1 and cancer metastasis 长链非编码RNA MALAT1与肿瘤转移

Biotarget Pub Date : 2019-05-05 DOI: 10.21037/BIOTARGET.2019.04.02

Jongchan Kim

引用次数: 1

Bronchioalveolar stem cells vindicated! 支气管肺泡干细胞被证明是正确的！

Biotarget Pub Date : 2019-04-23 DOI: 10.21037/BIOTARGET.2019.04.01

Matthew R. Jones, Jin-San Zhang, S. Bellusci

引用次数: 4

Use of a cross circulation platform to regenerate lungs with induced gastric injury 交叉循环平台在胃损伤后肺再生中的应用

Biotarget Pub Date : 2019-02-09 DOI: 10.21037/biotarget.2019.08.05

C. Kao, A. Parulekar

引用次数: 0

The “HDL receptor” scavenger receptor class B type 1 finesses the uptake of low-density lipoproteins into the subendothelial space of arteries “高密度脂蛋白受体”B类1型清道夫受体控制低密度脂蛋白进入动脉内皮下空间的摄取

Biotarget Pub Date : 2019-02-09 DOI: 10.21037/biotarget.2019.08.03

G. Getz, C. Reardon

引用次数: 1

What’s up with MALAT1? MALAT1怎么了？

Biotarget Pub Date : 2019-01-25 DOI: 10.21037/BIOTARGET.2019.01.01

G. Clawson

引用次数: 0

The new role of lncRNA MALAT1 as a tumor suppressor lncRNA MALAT1作为肿瘤抑制因子的新作用

Biotarget Pub Date : 2019-01-01 DOI: 10.21037/BIOTARGET.2019.01.02

Manuel Regouc, M. Pichler

引用次数: 0

Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy 表达嵌合抗原受体（CAR）的工程化自然杀伤细胞——肿瘤免疫治疗的一种有前景的方法

Biotarget Pub Date : 2019-01-01 DOI: 10.21037/BIOTARGET.2018.12.04

Brigitte Neuber, M. Schmitt

引用次数: 1

From prevention to cure, repurposing anti-viral vaccines for cancer immunotherapy. 从预防到治疗，将抗病毒疫苗重新用于癌症免疫疗法。

Biotarget Pub Date : 2018-12-01 DOI: 10.21037/biotarget.2018.12.03

Ons Mamai, Eswari Dodagatta-Marri, Rosemary J Akhurst

引用次数: 0

Effect of mammalian target of rapamycin signaling pathway on nerve regeneration 哺乳动物雷帕霉素信号通路靶点对神经再生的影响

Biotarget Pub Date : 2018-12-01 DOI: 10.21037/BIOTARGET.2018.12.01

Ziwei Huang, Jianwei Zhu, Jiacheng Sun, Wenjing Ma, Lingbin Wang, Qiuyu Zhang, Hualin Sun

{"title":"Effect of mammalian target of rapamycin signaling pathway on nerve regeneration","authors":"Ziwei Huang, Jianwei Zhu, Jiacheng Sun, Wenjing Ma, Lingbin Wang, Qiuyu Zhang, Hualin Sun","doi":"10.21037/BIOTARGET.2018.12.01","DOIUrl":"https://doi.org/10.21037/BIOTARGET.2018.12.01","url":null,"abstract":"Nerve injury is a serious clinical common problem not only caused by violence usually in traffic accident but also non-violence related disease like amyotrophic lateral sclerosis and other motor neuron diseases. All these diseases always come with severe consequences including loss of function and even to paralysis which are associated with significant high mortality. Although many useful treatments have been developed, completely recovery of damaged nerve function is usually hardly obtained. Because successful functional recovery of injured nerve lie in not only axon regeneration, neuronal survival but also reconstructing transmission of myelin-based electric nerve stimulation as well as re-innervation of denervated targets. Recent research has suggested that low intrinsic capacity of neuron may be genuinely responsible for regeneration failure. PI3K/Akt/mammalian target of rapamycin (mTOR) signaling pathway has been found playing crucial roles in the growth of central nervous system axons, and confirmed as a major intracellular signaling axis that control axon regeneration. In nerve dissection animal models, the mTOR activity was suppressed and protein synthesis was impaired, while reactivating this pathway successfully led to axon regeneration. Emerging evidence show that mTOR is required during multiple intricate physiological process in nerve regeneration. This review focuses on recent study which are mTOR related, introducing basic knowledge of mTOR including protein structure and its function in either physiological or pathological process, discussing the therapeutic potential of mTOR-based treatment.","PeriodicalId":92338,"journal":{"name":"Biotarget","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48246510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

The human papillomavirus vaccine: a potentially novel treatment for basaloid squamous cell carcinoma 人乳头瘤病毒疫苗：一种潜在的治疗基底样鳞状细胞癌的新方法

Biotarget Pub Date : 2018-12-01 DOI: 10.21037/BIOTARGET.2018.12.02

J. Floyd, R. Prasad

{"title":"The human papillomavirus vaccine: a potentially novel treatment for basaloid squamous cell carcinoma","authors":"J. Floyd, R. Prasad","doi":"10.21037/BIOTARGET.2018.12.02","DOIUrl":"https://doi.org/10.21037/BIOTARGET.2018.12.02","url":null,"abstract":"Inthe United States, 42.5% of patients ages 18–59 years who sought treatment forgenital infections throughout 2013–2014 were infected with any type of humanpapillomavirus (HPV) (1). The HPV affects millions of reproductive-age adultsin the United States and countless more throughout the world. In 2016, the U.S.FDA released a 9-valent HPV vaccine, commonly known as Gardasil-9, withintended uses in preventing the contraction of HPV and development of HPV-relateddiseases (2). However, new research suggests that this vaccine may have otherclinically significant treatment applications. A recent study published byNichols et al. in JAMA Dermatology entitled “Combined systemicand intratumoral administration of human papillomavirus vaccine to treatmultiple cutaneous basaloid squamous cell carcinomas”, which proposes the 9-valentHPV vaccine may be able to treat basaloid squamous cell carcinomas (bSCCs) (3).This novel finding has the potential to positively affect not only the millionsof people at risk for contracting HPV but also millions of patients sufferingfrom basal and squamous cell carcinomas, BCCs and SCCs, respectively.","PeriodicalId":92338,"journal":{"name":"Biotarget","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/BIOTARGET.2018.12.02","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43909351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0